Moderna vaccine effectiveness against symptomatic Omicron was 60% 2 weeks to 2 months after the second dose and 36% from 3 to 4 months after the second dose.
Original mRNA COVID vaccines protect young kids against Omicron, but efficacy wanes
Published in COVID-19
More from COVID-19More posts in COVID-19 »
- Caregiver stress lessened after pandemic lockdowns lifted, study finds
- Dip in alcohol consumption in early pandemic linked to less social drinking
- High-risk patients with COVID symptoms should use PCR rather than rapid tests, study suggests
- Peer support valuable intervention for health worker stress during COVID-19, study shows